BridgeMD
New treatment option for BPD - Bronchopulmonary Dysplasia
Official title Controlled Remote Monitoring and Optimization of Oxygen Therapy in Preterm Infants
ClinicalTrials.gov ID: NCT07161908
What this study is testing
- What it's testing
- The project is a national, prospective, multicenter, interventional pilot project focused on controlled remote monitoring and optimization of oxygen therapy for premature infants in the Czech Republic. The primary aim of the project is to prepare, test, and develop a proposal for a national methodology for the care of preterm newborns.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages up to 36
You may be able to join if
- infants born before 31+6 weeks gestation
- signed consent for participation in the project and consent for the processing of personal data
- diagnosed with bronchopulmonary dysplasia
- type of pulmonary ventilation - low-flow nasal cannulas
You likely can't join if
- unsigned consent for participation in the project and/or consent for the processing of personal data
- child diagnosed with conditions other than bronchopulmonary dysplasia (BPD) at high risk of long-term hypoxia - selected chronic cardiovascular...
- other chronic respiratory diseases besides BPD - e.g., cystic fibrosis, chronic aspiration
- insufficient therapy through long-term home oxygen therapy
- tracheostomy
The study team makes the final eligibility decision.
Where it's taking place
- České Budějovice, Czech Republic, Czechia
- Olomouc, Czech Republic, Czechia
- Prague, Czech Republic, Czechia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, up to 36 weeks. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include České Budějovice, Czech Republic, Czechia; Olomouc, Czech Republic, Czechia; Prague, Czech Republic, Czechia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.